Manfred D. Muenter

9.1k total citations · 1 hit paper
51 papers, 3.6k citations indexed

About

Manfred D. Muenter is a scholar working on Neurology, Cellular and Molecular Neuroscience and Rheumatology. According to data from OpenAlex, Manfred D. Muenter has authored 51 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Rheumatology. Recurrent topics in Manfred D. Muenter's work include Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (17 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Manfred D. Muenter is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (17 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Manfred D. Muenter collaborates with scholars based in United States, Canada and Austria. Manfred D. Muenter's co-authors include J. Eric Ahlskog, Arnold Aronson, John G. Nutt, Fletcher McDowell, L. Joseph Melton, Leonard T. Kurland, Margaret M. Hoehn, Charles H. Markham, Demetrius M. Maraganore and S G Diamond and has published in prestigious journals such as Annals of Internal Medicine, Brain and Neurology.

In The Last Decade

Manfred D. Muenter

48 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

2001 1.1k citations J. Eric Ahlskog, Manfred D. Muenter Movement Disorders profile →

Peers

Manfred D. Muenter

NEURO

CMN

NEURO

CN

MB

B. J. Snow Canada

Jean Hubble United States

M. R. Luquín Spain

J.F. Martí-Massó Spain

Paolo Martinelli Italy

N. Quinn United Kingdom

Beom S. Jeon South Korea

Tomoyoshi Kondo Japan

M. C. de Rijk Netherlands

V. Bonavita Italy

B. J. Snow Canada

Manfred D. Muenter

2.0k ×0.7

NEURO

1.2k ×0.9

CMN

309 ×0.8

NEURO

242 ×0.7

CN

345 ×1.1

MB

Citations per year, relative to Manfred D. Muenter Manfred D. Muenter (= 1×) peers B. J. Snow

Countries citing papers authored by Manfred D. Muenter

Since Specialization

Citations

This map shows the geographic impact of Manfred D. Muenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred D. Muenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred D. Muenter more than expected).

Fields of papers citing papers by Manfred D. Muenter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred D. Muenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred D. Muenter. The network helps show where Manfred D. Muenter may publish in the future.

Co-authorship network of co-authors of Manfred D. Muenter

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred D. Muenter. A scholar is included among the top collaborators of Manfred D. Muenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred D. Muenter. Manfred D. Muenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tong, Junchao, Henry Wong, Mark Guttman, et al.. (2009). Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain. 133(1). 172–188. 160 indexed citations

2.

Wszolek, Z., Katrina Gwinn, Manfred D. Muenter, et al.. (2002). Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathologica. 103(4). 344–350. 12 indexed citations

3.

Gwinn, Katrina, Nitin D. Mehta, Matthew J. Farrer, et al.. (2000). Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathologica. 99(6). 663–672. 134 indexed citations

4.

Caviness, John N., Benn E. Smith, J. Clarke Stevens, et al.. (2000). Motor unit changes in sporadic idiopathic Parkinson's disease. Movement Disorders. 15(2). 238–243. 20 indexed citations

5.

Caviness, John N., Katrina Gwinn, Charles H. Adler, & Manfred D. Muenter. (2000). Electrophysiological observations in hereditary parkinsonism-dementia with Lewy body pathology. Movement Disorders. 15(1). 140–145. 14 indexed citations

6.

Muenter, Manfred D., Lysia S. Forno, Oleh Hornykiewicz, et al.. (1998). Hereditary form of parkinsonism—dementia. Annals of Neurology. 43(6). 768–781. 136 indexed citations

7.

Evidente, Virgilio Gerald H., Katrina Gwinn, John N. Caviness, Manfred D. Muenter, & Donald W. Mulder. (1998). Early cinematographic cases of postencephalitic parkinsonism and other movement disorders. Movement Disorders. 13(1). 167–169. 7 indexed citations

8.

Hutton, J. Thomas, William C. Koller, J. Eric Ahlskog, et al.. (1996). Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease. Neurology. 46(4). 1062–1065. 64 indexed citations

9.

Winkelmann, R.K., et al.. (1995). Postzoster eruptions: granuloma annulare, granulomatous vasculitis and pseudolymphoma. 5(6). 470–476. 9 indexed citations

10.

Olanow, C. Warren, Stanley Fahn, Manfred D. Muenter, et al.. (1994). A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease. Movement Disorders. 9(1). 40–47. 166 indexed citations

11.

Caviness, John N. & Manfred D. Muenter. (1991). An unusual cause of recurrent chorea. Movement Disorders. 6(4). 355–357. 16 indexed citations

12.

Muenter, Manfred D., Jasper R. Daube, John N. Caviness, & Patricia Miller. (1991). Treatment of Essential Tremor With Methazolamide. Mayo Clinic Proceedings. 66(10). 991–997. 36 indexed citations

13.

Diamond, S G, Charles H. Markham, Margaret M. Hoehn, Fletcher McDowell, & Manfred D. Muenter. (1989). Effect of age at onset on progression and mortality in Parkinson's disease. Neurology. 39(9). 1187–1187. 118 indexed citations

14.

Ahlskog, J. Eric, et al.. (1988). Controlled-Release Sinemet (CR-4): A Double-Blind Crossover Study in Patients With Fluctuating Parkinson's Disease. Mayo Clinic Proceedings. 63(9). 876–886. 47 indexed citations

15.

Ahlskog, J. Eric & Manfred D. Muenter. (1988). Treatment of Parkinson's Disease With Pergolide: A Double-Blind Study. Mayo Clinic Proceedings. 63(10). 969–978. 29 indexed citations

16.

Nutt, John G., Manfred D. Muenter, Arnold Aronson, Leonard T. Kurland, & L. Joseph Melton. (1988). Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Movement Disorders. 3(3). 188–194. 339 indexed citations

17.

Muenter, Manfred D., Nansie S. Sharpless, & Gertrude M. Tyce. (1972). Plasma 3-0-Methyldopa in L-Dopa Therapy of Parkinson’s Disease. Mayo Clinic Proceedings. 47(6). 389–395.

18.

Muenter, Manfred D. & Gertrude M. Tyce. (1971). L-DOPA THERAPY OF PARKINSON’S DISEASE: PLASMA L-DOPA CONCENTRATION, THERAPEUTIC RESPONSE, AND SIDE EFFECTS. Mayo Clinic Proceedings. 46(4). 231–239. 2 indexed citations

19.

Muenter, Manfred D.. (1971). Levodopa. Annals of Internal Medicine. 75(5). 795–797. 6 indexed citations

20.

Tyce, Gertrude M., et al.. (1970). DIHYDROXYPHENYLALANINE (DOPA) IN PLASM DURING DOPA TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE. Mayo Clinic Proceedings. 45(6). 438–443.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact